Phosphorylation of blood vessel vasodilator-stimulated phosphoprotein at Serine 239 as a functional biochemical marker of endothelial nitric oxide/cyclic GMP signaling

Molecular Pharmacology

Volumn 61, Issue 2, 2002, Pages 312-319

  Ibarra Alvarado, César ^a,b,c   Galle, Jan ^b   Melichar, Volker O ^b   Mameghani, Alexander ^b   Schmidt, Harald H H W ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 8 BROMO CYCLIC AMP; 8 BROMO CYCLIC GMP; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PROSTACYCLIN; PROTEIN KINASE; SERINE;

ANIMAL TISSUE; AORTA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM; VASODILATATION;

8-BROMO CYCLIC ADENOSINE MONOPHOSPHATE; ANIMALS; AORTA; BIOLOGICAL MARKERS; CELL ADHESION MOLECULES; CYCLIC GMP; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; FEMALE; KINETICS; MALE; MICROFILAMENT PROTEINS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITROPRUSSIDE; OXADIAZOLES; PHOSPHOPROTEINS; PHOSPHORYLATION; QUINOXALINES; RABBITS; SERINE; SIGNAL TRANSDUCTION; THIONUCLEOTIDES;

EID: 0036153809     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.2.312     Document Type: Article

References (40)

1. Dephosphorylation of the focal adhesion protein VASP in vitro and in intact human platelets
2. Monoclonal antibodies against the focal adhesion protein VASP revealing epitopes involved in the interaction with two VASP binding proteins and VASP phosphorylation
3. Mutations in Drosophila enabled and rescue by human vasodilator-stimulated phosphoprotein (VASP) indicate important functional roles for Ena/VASP homology domain 1 (EVH1) and EVH2 domains
4. The vasodilator-stimulated phosphoprotein (VASP) is involved in cGMP- and cAMP-mediated inhibition of agonist-induced platelet aggregation, but is dispensable for smooth muscle function
5. Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation
6. cAMPand cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets
7. Inhibition of cyclic GMP-dependent protein kinase-mediated effects by (Rp)-8-bromo-PET-cyclic GMPS
8. Loading and transfer control for northern hybridization
9. Expression of cGMP-dependent protein kinase I and phosphorylation of its substrate, vasodilator-stimulated phosphoprotein, in human endothelial cells of different origin
10. Signal transduction by cGMP-dependent protein kinases and their emerging roles in the regulation of cell adhesion and gene expression
11. Endothelium-derived relaxing and contracting factors
12. Interleukin-1 beta induces the formation of nitric oxide in isolated juxtaglomerular cells: Influence on renin secretion
13. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity
14. Purification of a vasodilator-regulated phosphoprotein from human platelets
15. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators
16. Megakaryocyte hyperplasia and enhanced agonist-induced platelet activation in vasodilator-stimulated phosphoprotein knockout mice
17. Rising behind NO cGMP-dependent protein kinases
18. Phosphorylation of focal adhesion vasodilator-stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition
19. Direct evidence for crossactivation of cGMP-dependent protein kinase by cAMP in pig coronary arteries
20. Interactions between NO and reactive oxygen species: Pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure
21. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
22. 2+ by cAMP in vascular smooth muscle cells
23. High expression of the focal adhesion- and microfilament-associated protein VASP in vascular smooth muscle and endothelial cells of the intact human vessel wall
24. Increased adhesion and aggregation of platelets lacking cyclic guanosine 3′,5′-monophosphate kinase I
25. Expression of cGMP-dependent protein kinase I and its substrate VASP in neointimal cells of the injured rat carotid artery
26. Cyclic GMP: Synthesis, metabolism, and function. Introduction and some historical comments
27. A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family
28. Vasodilator-stimulated phosphoprotein serine 239 phosphorylation as a sensitive monitor of defective nitric oxide/cGMP signaling and endothelial dysfunction
29. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
30. A simplification of the protein assay method of Lowry et al. which is more generally applicable
31. Defective smooth muscle regulation in cGMP kinase I-deficient mice
32. Structure and function of cGMP-dependent protein kinases
33. 2+ and cAMP messenger system in regulation of airway smooth muscle contraction
34. The 46/50 kDa phosphoprotein VASP purified from human platelets is a novel protein associated with actin filaments and focal contacts
35. Molecular mechanisms of platelet activation
36. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody
37. Signal transduction and regulation in smooth muscle
38. Quantitative electronic imaging of gel flourescence with CCD cameras: Applications in molecular biology
39. Vasodilator-stimulated protein phosphorylation in platelets is mediated by cAMP- and cGMP-dependent protein kinases